Overview
- Nucleus Genomics and Herasight now offer prospective parents embryo rankings for traits such as IQ at prices ranging from about $6,000 to $50,000.
- Some tech executives view polygenic embryo screening as a tool to cultivate higher intelligence in children in anticipation of future artificial intelligence risks.
- Geneticists note current polygenic scores account for only small average IQ gains of three to four points and carry unintended trait trade-offs due to pleiotropy.
- Bioethicists warn commercial selection services risk deepening socioeconomic divides and echo eugenic-era dynamics by privileging those who can afford the tests.
- The United States maintains minimal federal oversight of polygenic embryo screening, contrasting with stricter regulatory regimes in countries like the United Kingdom.